Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

  • Quartier P
  • Grom A
  • Ruperto N
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Quartier, P., Grom, A., Ruperto, N., Brunner, H., Schikler, K., Erguven, M., … Lovell, D. (2014). Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis. Pediatric Rheumatology, 12(S1). https://doi.org/10.1186/1546-0096-12-s1-p66

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free